Until now, several reports have focused on the role of soluble CEACAM1 in tumor patients and found elevated serum CEACAM1 level was relevant to tumor presence, progression and survival for patients with non-small cell lung, pancreatic cancers and malignant melanoma [13–15]. Here, CEACAM1 is linked to melanoma.